These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The influence of tamoxifen on plasma coagulation and serous fibrinolysis.
    Author: Jankowski J, Ramlau C, Kopczynski Z, Boryska M.
    Journal: Eur J Gynaecol Oncol; 1993; 14 Suppl():155-8. PubMed ID: 8200368.
    Abstract:
    Selected parameters of coagulation and fibrinolysis were determined in 25 postmenopausal women, treated chronically for breast cancer with the use of tamoxifen. The significant influence of tamoxifen therapy on the serous fibrinolysis parameters was found. The time of euglobulin lysis was shorter, the concentration of alpha 2-antiplasmin decreased, and plasminogen concentration increased. The content of antithrombin III, fibrinogen, and caolin-cephalin time did not change significantly during therapy, except the prothrombin rate which increased. Tamoxifen is an important medicine with beneficial influence on the fibrinolytic system, without affecting the serous coagulation system.
    [Abstract] [Full Text] [Related] [New Search]